Loading…

Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling

Cannabinoids (CBs) are neuroprotective in vivo and in vitro, but the mechanisms of their actions are unknown. The aim of this study was to elucidate the signaling pathways that mediate the protective effect of CBs on primary cultured neurons. The neurotoxin S-AMPA induced significant death of rat pr...

Full description

Saved in:
Bibliographic Details
Published in:Molecular and cellular neuroscience 2005, Vol.28 (1), p.189-194
Main Authors: Molina-Holgado, Francisco, Pinteaux, Emmanuel, Heenan, Laura, Moore, Jonathan D., Rothwell, Nancy J., Gibson, Rosemary M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133
cites cdi_FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133
container_end_page 194
container_issue 1
container_start_page 189
container_title Molecular and cellular neuroscience
container_volume 28
creator Molina-Holgado, Francisco
Pinteaux, Emmanuel
Heenan, Laura
Moore, Jonathan D.
Rothwell, Nancy J.
Gibson, Rosemary M.
description Cannabinoids (CBs) are neuroprotective in vivo and in vitro, but the mechanisms of their actions are unknown. The aim of this study was to elucidate the signaling pathways that mediate the protective effect of CBs on primary cultured neurons. The neurotoxin S-AMPA induced significant death of rat primary cortical neurons, which was inhibited by the CB agonist HU-210. Antagonists selective for CB 1 or CB 2 receptors (AM 281 or AM 630, respectively) reversed the neuroprotective effect of HU-210 on S-AMPA-induced cell death. HU-210 triggered activation of AKT, but not activation of the ERK1/2, JNK or p38 signaling pathways. The phosphatidylinositol 3-kinase (PI 3-K) inhibitors LY294002 and wortmannin prevented phosphorylation of AKT in response to HU-210, and reversed the neuroprotective effect of HU-210 on S-AMPA-induced excitotoxicity. Thus the PI 3-K/AKT signaling pathway mediates the neuroprotective effect of exogenous cannabinoids such as HU-210 in primary CNS neurons.
doi_str_mv 10.1016/j.mcn.2004.09.004
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17529444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1044743104002179</els_id><sourcerecordid>17529444</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133</originalsourceid><addsrcrecordid>eNp9UcFuEzEUXCEQLYUP4IJ84rbb57V3nRWnqgKKqODSni3Hfm4cNnawnUr5Dn6Yt0okbpxmpDdvpJlpmvccOg58vN52Oxu7HkB2MHUEL5pLDtPQTqJXLxcuZauk4BfNm1K2ADD0k3jdXPBhBDUN4rL58wMPOe1zqmhreEaG3hMrLHlWN8jKMRLUYJk1MZp1iCk4dvfY9hxYiGyfw87kI7Mpk8jMLC5-sTCTke3QBVPRsfWR7Tep7DemBnecyaSEmmYm2l8hmoLXN98fWAlP0dDt6W3zypu54LszXjWPXz4_3N619z-_fru9uW-tWPW1tc4gGOLSKKe4QOGVFxbsavCAQo0gYVjS8BEmidxNHPveSeVHs-q5EFfNx5Mvxf99wFL1LhSL82wipkPRXFFdUkoS8pPQ5lRKRq_PsTUHvSyht5qW0MsSGiZNQD8fzuaHNfXw7-NcPQk-nQRIEZ8DZl1swGips0wLaJfCf-z_Anh5nBY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17529444</pqid></control><display><type>article</type><title>Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling</title><source>ScienceDirect Freedom Collection</source><creator>Molina-Holgado, Francisco ; Pinteaux, Emmanuel ; Heenan, Laura ; Moore, Jonathan D. ; Rothwell, Nancy J. ; Gibson, Rosemary M.</creator><creatorcontrib>Molina-Holgado, Francisco ; Pinteaux, Emmanuel ; Heenan, Laura ; Moore, Jonathan D. ; Rothwell, Nancy J. ; Gibson, Rosemary M.</creatorcontrib><description>Cannabinoids (CBs) are neuroprotective in vivo and in vitro, but the mechanisms of their actions are unknown. The aim of this study was to elucidate the signaling pathways that mediate the protective effect of CBs on primary cultured neurons. The neurotoxin S-AMPA induced significant death of rat primary cortical neurons, which was inhibited by the CB agonist HU-210. Antagonists selective for CB 1 or CB 2 receptors (AM 281 or AM 630, respectively) reversed the neuroprotective effect of HU-210 on S-AMPA-induced cell death. HU-210 triggered activation of AKT, but not activation of the ERK1/2, JNK or p38 signaling pathways. The phosphatidylinositol 3-kinase (PI 3-K) inhibitors LY294002 and wortmannin prevented phosphorylation of AKT in response to HU-210, and reversed the neuroprotective effect of HU-210 on S-AMPA-induced excitotoxicity. Thus the PI 3-K/AKT signaling pathway mediates the neuroprotective effect of exogenous cannabinoids such as HU-210 in primary CNS neurons.</description><identifier>ISSN: 1044-7431</identifier><identifier>EISSN: 1095-9327</identifier><identifier>DOI: 10.1016/j.mcn.2004.09.004</identifier><identifier>PMID: 15607953</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cannabinoids - pharmacology ; Cells, Cultured ; Cerebral Cortex - cytology ; Cerebral Cortex - drug effects ; Cerebral Cortex - metabolism ; Dronabinol - analogs &amp; derivatives ; Dronabinol - pharmacology ; Enzyme Inhibitors - pharmacology ; Excitatory Amino Acid Agonists - pharmacology ; Nerve Degeneration - chemically induced ; Nerve Degeneration - drug therapy ; Nerve Degeneration - prevention &amp; control ; Neurons - drug effects ; Neurons - metabolism ; Neuroprotective Agents - pharmacology ; Neurotoxins - antagonists &amp; inhibitors ; Phosphatidylinositol 3-Kinases - drug effects ; Phosphatidylinositol 3-Kinases - metabolism ; Protein Serine-Threonine Kinases - drug effects ; Protein Serine-Threonine Kinases - metabolism ; Proto-Oncogene Proteins - drug effects ; Proto-Oncogene Proteins - metabolism ; Proto-Oncogene Proteins c-akt ; Rats ; Rats, Sprague-Dawley ; Receptor, Cannabinoid, CB1 - antagonists &amp; inhibitors ; Receptor, Cannabinoid, CB1 - metabolism ; Receptor, Cannabinoid, CB2 - antagonists &amp; inhibitors ; Receptor, Cannabinoid, CB2 - metabolism ; Signal Transduction - drug effects ; Signal Transduction - physiology</subject><ispartof>Molecular and cellular neuroscience, 2005, Vol.28 (1), p.189-194</ispartof><rights>2004 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133</citedby><cites>FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15607953$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Molina-Holgado, Francisco</creatorcontrib><creatorcontrib>Pinteaux, Emmanuel</creatorcontrib><creatorcontrib>Heenan, Laura</creatorcontrib><creatorcontrib>Moore, Jonathan D.</creatorcontrib><creatorcontrib>Rothwell, Nancy J.</creatorcontrib><creatorcontrib>Gibson, Rosemary M.</creatorcontrib><title>Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling</title><title>Molecular and cellular neuroscience</title><addtitle>Mol Cell Neurosci</addtitle><description>Cannabinoids (CBs) are neuroprotective in vivo and in vitro, but the mechanisms of their actions are unknown. The aim of this study was to elucidate the signaling pathways that mediate the protective effect of CBs on primary cultured neurons. The neurotoxin S-AMPA induced significant death of rat primary cortical neurons, which was inhibited by the CB agonist HU-210. Antagonists selective for CB 1 or CB 2 receptors (AM 281 or AM 630, respectively) reversed the neuroprotective effect of HU-210 on S-AMPA-induced cell death. HU-210 triggered activation of AKT, but not activation of the ERK1/2, JNK or p38 signaling pathways. The phosphatidylinositol 3-kinase (PI 3-K) inhibitors LY294002 and wortmannin prevented phosphorylation of AKT in response to HU-210, and reversed the neuroprotective effect of HU-210 on S-AMPA-induced excitotoxicity. Thus the PI 3-K/AKT signaling pathway mediates the neuroprotective effect of exogenous cannabinoids such as HU-210 in primary CNS neurons.</description><subject>Animals</subject><subject>Cannabinoids - pharmacology</subject><subject>Cells, Cultured</subject><subject>Cerebral Cortex - cytology</subject><subject>Cerebral Cortex - drug effects</subject><subject>Cerebral Cortex - metabolism</subject><subject>Dronabinol - analogs &amp; derivatives</subject><subject>Dronabinol - pharmacology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Excitatory Amino Acid Agonists - pharmacology</subject><subject>Nerve Degeneration - chemically induced</subject><subject>Nerve Degeneration - drug therapy</subject><subject>Nerve Degeneration - prevention &amp; control</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Neurotoxins - antagonists &amp; inhibitors</subject><subject>Phosphatidylinositol 3-Kinases - drug effects</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Protein Serine-Threonine Kinases - drug effects</subject><subject>Protein Serine-Threonine Kinases - metabolism</subject><subject>Proto-Oncogene Proteins - drug effects</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Proto-Oncogene Proteins c-akt</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, Cannabinoid, CB1 - antagonists &amp; inhibitors</subject><subject>Receptor, Cannabinoid, CB1 - metabolism</subject><subject>Receptor, Cannabinoid, CB2 - antagonists &amp; inhibitors</subject><subject>Receptor, Cannabinoid, CB2 - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - physiology</subject><issn>1044-7431</issn><issn>1095-9327</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9UcFuEzEUXCEQLYUP4IJ84rbb57V3nRWnqgKKqODSni3Hfm4cNnawnUr5Dn6Yt0okbpxmpDdvpJlpmvccOg58vN52Oxu7HkB2MHUEL5pLDtPQTqJXLxcuZauk4BfNm1K2ADD0k3jdXPBhBDUN4rL58wMPOe1zqmhreEaG3hMrLHlWN8jKMRLUYJk1MZp1iCk4dvfY9hxYiGyfw87kI7Mpk8jMLC5-sTCTke3QBVPRsfWR7Tep7DemBnecyaSEmmYm2l8hmoLXN98fWAlP0dDt6W3zypu54LszXjWPXz4_3N619z-_fru9uW-tWPW1tc4gGOLSKKe4QOGVFxbsavCAQo0gYVjS8BEmidxNHPveSeVHs-q5EFfNx5Mvxf99wFL1LhSL82wipkPRXFFdUkoS8pPQ5lRKRq_PsTUHvSyht5qW0MsSGiZNQD8fzuaHNfXw7-NcPQk-nQRIEZ8DZl1swGips0wLaJfCf-z_Anh5nBY</recordid><startdate>2005</startdate><enddate>2005</enddate><creator>Molina-Holgado, Francisco</creator><creator>Pinteaux, Emmanuel</creator><creator>Heenan, Laura</creator><creator>Moore, Jonathan D.</creator><creator>Rothwell, Nancy J.</creator><creator>Gibson, Rosemary M.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>2005</creationdate><title>Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling</title><author>Molina-Holgado, Francisco ; Pinteaux, Emmanuel ; Heenan, Laura ; Moore, Jonathan D. ; Rothwell, Nancy J. ; Gibson, Rosemary M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Cannabinoids - pharmacology</topic><topic>Cells, Cultured</topic><topic>Cerebral Cortex - cytology</topic><topic>Cerebral Cortex - drug effects</topic><topic>Cerebral Cortex - metabolism</topic><topic>Dronabinol - analogs &amp; derivatives</topic><topic>Dronabinol - pharmacology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Excitatory Amino Acid Agonists - pharmacology</topic><topic>Nerve Degeneration - chemically induced</topic><topic>Nerve Degeneration - drug therapy</topic><topic>Nerve Degeneration - prevention &amp; control</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Neurotoxins - antagonists &amp; inhibitors</topic><topic>Phosphatidylinositol 3-Kinases - drug effects</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Protein Serine-Threonine Kinases - drug effects</topic><topic>Protein Serine-Threonine Kinases - metabolism</topic><topic>Proto-Oncogene Proteins - drug effects</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Proto-Oncogene Proteins c-akt</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, Cannabinoid, CB1 - antagonists &amp; inhibitors</topic><topic>Receptor, Cannabinoid, CB1 - metabolism</topic><topic>Receptor, Cannabinoid, CB2 - antagonists &amp; inhibitors</topic><topic>Receptor, Cannabinoid, CB2 - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Molina-Holgado, Francisco</creatorcontrib><creatorcontrib>Pinteaux, Emmanuel</creatorcontrib><creatorcontrib>Heenan, Laura</creatorcontrib><creatorcontrib>Moore, Jonathan D.</creatorcontrib><creatorcontrib>Rothwell, Nancy J.</creatorcontrib><creatorcontrib>Gibson, Rosemary M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Molecular and cellular neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Molina-Holgado, Francisco</au><au>Pinteaux, Emmanuel</au><au>Heenan, Laura</au><au>Moore, Jonathan D.</au><au>Rothwell, Nancy J.</au><au>Gibson, Rosemary M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling</atitle><jtitle>Molecular and cellular neuroscience</jtitle><addtitle>Mol Cell Neurosci</addtitle><date>2005</date><risdate>2005</risdate><volume>28</volume><issue>1</issue><spage>189</spage><epage>194</epage><pages>189-194</pages><issn>1044-7431</issn><eissn>1095-9327</eissn><abstract>Cannabinoids (CBs) are neuroprotective in vivo and in vitro, but the mechanisms of their actions are unknown. The aim of this study was to elucidate the signaling pathways that mediate the protective effect of CBs on primary cultured neurons. The neurotoxin S-AMPA induced significant death of rat primary cortical neurons, which was inhibited by the CB agonist HU-210. Antagonists selective for CB 1 or CB 2 receptors (AM 281 or AM 630, respectively) reversed the neuroprotective effect of HU-210 on S-AMPA-induced cell death. HU-210 triggered activation of AKT, but not activation of the ERK1/2, JNK or p38 signaling pathways. The phosphatidylinositol 3-kinase (PI 3-K) inhibitors LY294002 and wortmannin prevented phosphorylation of AKT in response to HU-210, and reversed the neuroprotective effect of HU-210 on S-AMPA-induced excitotoxicity. Thus the PI 3-K/AKT signaling pathway mediates the neuroprotective effect of exogenous cannabinoids such as HU-210 in primary CNS neurons.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15607953</pmid><doi>10.1016/j.mcn.2004.09.004</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1044-7431
ispartof Molecular and cellular neuroscience, 2005, Vol.28 (1), p.189-194
issn 1044-7431
1095-9327
language eng
recordid cdi_proquest_miscellaneous_17529444
source ScienceDirect Freedom Collection
subjects Animals
Cannabinoids - pharmacology
Cells, Cultured
Cerebral Cortex - cytology
Cerebral Cortex - drug effects
Cerebral Cortex - metabolism
Dronabinol - analogs & derivatives
Dronabinol - pharmacology
Enzyme Inhibitors - pharmacology
Excitatory Amino Acid Agonists - pharmacology
Nerve Degeneration - chemically induced
Nerve Degeneration - drug therapy
Nerve Degeneration - prevention & control
Neurons - drug effects
Neurons - metabolism
Neuroprotective Agents - pharmacology
Neurotoxins - antagonists & inhibitors
Phosphatidylinositol 3-Kinases - drug effects
Phosphatidylinositol 3-Kinases - metabolism
Protein Serine-Threonine Kinases - drug effects
Protein Serine-Threonine Kinases - metabolism
Proto-Oncogene Proteins - drug effects
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins c-akt
Rats
Rats, Sprague-Dawley
Receptor, Cannabinoid, CB1 - antagonists & inhibitors
Receptor, Cannabinoid, CB1 - metabolism
Receptor, Cannabinoid, CB2 - antagonists & inhibitors
Receptor, Cannabinoid, CB2 - metabolism
Signal Transduction - drug effects
Signal Transduction - physiology
title Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A28%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroprotective%20effects%20of%20the%20synthetic%20cannabinoid%20HU-210%20in%20primary%20cortical%20neurons%20are%20mediated%20by%20phosphatidylinositol%203-kinase/AKT%20signaling&rft.jtitle=Molecular%20and%20cellular%20neuroscience&rft.au=Molina-Holgado,%20Francisco&rft.date=2005&rft.volume=28&rft.issue=1&rft.spage=189&rft.epage=194&rft.pages=189-194&rft.issn=1044-7431&rft.eissn=1095-9327&rft_id=info:doi/10.1016/j.mcn.2004.09.004&rft_dat=%3Cproquest_cross%3E17529444%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17529444&rft_id=info:pmid/15607953&rfr_iscdi=true